Neuberger Berman High Yield Strategies Fund Inc.
NHS · AMEX
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.42 | 0.04 | 0.02 |
| FCF Yield | 9.77% | -3.20% | -15.22% | 20.35% |
| EV / EBITDA | 7.89 | -32.45 | -13.20 | 20.20 |
| Quality | ||||
| ROIC | 11.93% | 4.01% | -10.26% | 9.82% |
| Gross Margin | 100.00% | 100.00% | 79.16% | 100.00% |
| Cash Conversion Ratio | 0.56 | -1.57 | 1.45 | 3.89 |
| Growth | ||||
| Revenue 3-Year CAGR | 63.62% | -8.84% | 1.30% | 4.97% |
| Free Cash Flow Growth | 460.82% | 87.99% | -146.71% | 392.49% |
| Safety | ||||
| Net Debt / EBITDA | 2.20 | -8.62 | -3.64 | 1.08 |
| Interest Coverage | 11.89 | 3.86 | -29.44 | 67.47 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -761.39 | -147.35 | -179.36 | -4,724.67 |